truvada
Latest
Ads on Facebook are spreading misinformation about anti-HIV drugs
While many are focused on Facebook's unwillingness to curb false political ads, there appears to be another misinformation campaign going unchecked. The Guardian and GLAAD have noted that personal injury law firms continue to run Facebook ads making false claims about the risks of Truvada, a drug meant to reduce the likelihood of HIV transmission. Some float the specters of bone loss and kidney damage despite evidence that the risks of either are "not clinically significant," according to the San Francisco AIDS Foundation.
A generic HIV prevention drug should arrive in 2021
Pharmaceutical giant Gilead has agreed to release its exclusive patent to manufacture and sell the HIV-prevention drug Truvada. This means we could see a generic version of the pre-exposure prophylaxis (or PrEP) on the market earlier than expected. The news is seen as a win for individuals who may be at a greater risk of contracting HIV.
